Private Market View

Pangea Bio

Drug Discovery · Kent, United Kingdom · Founded 2021 · Privately Held (backing)

Last price · $/share
Implied valuation
$80.0M
Total raised
$21.7M
Last round
Early Stage VC (Series A)
Oct 2023
What is Pangea Bio worth?
$80.0Mlast known valuation

Pangea Bio last raised $15.6M in its Early Stage VC (Series A) (Oct 2023).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 19 names
  • ·Watchlist + deal alerts for Pangea Bio
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Oct 2023Early Stage VC (Series A)$15.6M

How Pangea Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Pangea Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Pangea Bio worth?
Pangea Bio's last known valuation is $80.0M.
How much has Pangea Bio raised?
Pangea Bio has raised $21.7M in total funding across 1 recorded rounds.
When did Pangea Bio last raise?
Pangea Bio last raised in Oct 2023 (Early Stage VC (Series A)), raising $15.6M.